Pangraf 5 mg Capsule
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Pangraf 5 mg Capsule contains tacrolimus, a calcineurin-inhibitor immunosuppressant. Its labelling describes it for the prevention of organ rejection in patients who have received a liver, heart, or kidney transplant, used in combination with other medicines. It is described as lowering the activity of the immune system so that the body does not attack the transplanted organ.
Product Information
The following description reflects information associated with tacrolimus and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the prevention of organ rejection after liver, heart, or kidney transplantation
- Described as used in combination with other medicines
- Described as lowering the activity of the immune system so it does not attack the transplanted organ
Described Dosage & Administration
- The dose and frequency are set by the doctor after reviewing body weight, the type of transplant, and other medicines being taken
- Taken by mouth daily at about the same time each day, without skipping any dose
- Treatment should not be stopped even when the patient feels well
Described Side Effects
Described side effects include:
- Worsening of diabetes and of kidney problems, which are described as needing serious medical attention
- Tremors
- Increased susceptibility to infection (reduced immunity)
- High blood pressure
- Headache
- Difficulty sleeping (insomnia)
Because it lowers immunity, the risk of infection is described as higher than normal. Any severe or worsening side effect requires prompt medical attention.
Precautions
- The doctor should be told about any kidney, liver, diabetes, high blood pressure, or heart problems
- Sun and UV-light exposure should be limited, as immunosuppressants are described as increasing the risk of skin cancer
- Men and women should use effective contraception during treatment to prevent pregnancy
- Frequent blood-pressure checks and other tests are described as recommended before and during treatment
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains tacrolimus and is used with other medicines to prevent organ rejection after a liver, heart, or kidney transplant, by lowering the activity of the immune system. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as taken by mouth daily at about the same time each day, at the dose set by the doctor, without skipping doses. Treatment should not be stopped even when the patient feels well.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.